<DOC>
	<DOCNO>NCT00328978</DOCNO>
	<brief_summary>The purpose study ass compare side effect profile , safety , tolerability efficacy schizophrenic schizoaffective subject non- partially- responsive 800 mg/day quetiapine treat either 800 mg/day 800 mg/day quetiapine 8 week .</brief_summary>
	<brief_title>Seroquel STACK Study Schizophrenic Schizoaffective Subjects</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Men woman , age 1865 year persistent positive negative symptom PANSS total score â‰¥ 70 &lt; 110 Clinical Global Improvement ( CGI ) Severity Illness score least 4 ( moderately ill ) screening . Subjects may treat outpatient . Subjects must give write informed consent . Subjects psychiatric , medical behavioural comorbid disorder may interfere study conduct interpretation . Female childbearing potential , unless subject use reliable method contraception Subjects alcohol psychoactivesubstance dependence full remission significant alcohol substance abuse past 3 month exclude . Laboratory test result outside range reference consider investigator clinically significant . Inability respect visit schedule know intolerance quetiapine 800mg/day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
</DOC>